Dr. Futscher received his BS in Biology & Chemistry from Valparaiso University in 1983.
Dr. Futscher trained in the laboratory of Dr. Leonard C. Erickson and was awarded a PhD in Pharmacology & Toxicology in 1990 from Loyola University.
Post-doctoral training was performed in Dr. William S. Dalton's laboratory at the Arizona Cancer Center from 1990 - 1994.
Dr. Futscher was appointed Assistant Professor in 1994, promoted to Associate Professor in 2000, and Full Professor of Pharmacology & Toxicology in 2004.
The Futscher lab’s primary research focus is cancer epigenetics. We use comprehensive genomic approaches to investigate the epigenomic dysfunction that drives human cancer. The use of genome-wide approaches guarantees the capture of all of the information regarding epigenetic change in human cancer.
From this comprehensive data of the normal and diseased human epigenomes, we employ advanced in silico and molecular biological approaches to generate new knowledge and discover the decisive epigenetic events that drive human carcinogenesis. The long-term objective of these studies is the development of epigenetic markers cancer detection, therapy monitoring, prognostication, and the identification of novel targets for molecularly directed cancer therapy.